[Pharmacological profile of a new non tricyclic antidepressant: oxaflozane (1,766 Cerm)].
D000661:Amphetamine; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000187:drug effects*; D004353:Drug Evaluation, Preclinical; D004357:Drug Synergism; D006845:Hydrocarbons, Fluorinated / Q000494:pharmacology; D051379:Mice; D009025:Morpholines; D010078:Oxazines / Q000494:pharmacology*; D010276:Parasympatholytics; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D014149:Tranquilizing Agents / Q000037:antagonists & inhibitors
D000928:Antidepressive Agents; D006845:Hydrocarbons, Fluorinated; D009025:Morpholines; D010078:Oxazines; D010276:Parasympatholytics; D014149:Tranquilizing Agents; D012110:Reserpine; D000661:Amphetamine; C005357:oxaflozane
Profil pharmacologique d'un nouvel antidépresseur non tricyclique: l'oxaflozane (1.766 Cerm)